Journal article

Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme

JD Mellor, P Van Koeverden, SWK Yip, A Thakerar, SW Kirsa, M Michael

Internal Medicine Journal | WILEY | Published : 2012

DOI: 10.1111/j.1445-5994.2012.02751.x

Citation metrics

12Web of Science
13Scopus

Keywords

Evidence-Based Medicine
Chemotherapy
Science & Technology
Off-Label
Drug Prescriptions
Practice Guidelines As Topic
Health Services Accessibility
General & Internal Medicine
Physician'S Practice Patterns
Pbs
Practice Patterns, Physicians'
Financing, Government
Clinical Protocols
Unlicensed
Off-Label Use
Insurance, Pharmaceutical Services
Oncology
Drug Utilization
Tertiary Care Centers
Haematology
Antineoplastic Agents
Humans
Academic Medical Centers
Neoplasms
Victoria
Drug Approval
Socioeconomic Factors
Life Sciences & Biomedicine
Medicine, General & Internal
Guideline Adherence
Cancer Care Facilities